IMV (IMV) Stock Price, News & Analysis

Company Overview

IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 15,761 shs
• Average Volume: 56,822 shs
• Market Capitalization: C$13.12 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IMV Stock Analysis - Frequently Asked Questions

When did IMV's stock split?

Shares of IMV reverse split on Monday, December 12th 2022.The 1-10 reverse split was announced on Monday, December 12th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of IMV?

Shares of IMV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of IMV own?

Based on aggregate information from My MarketBeat watchlists, some other companies that IMV investors own include Aurora Cannabis (ACB), 10094 (IRD.TO) (IRD), Manulife Financial (MFC), Village Farms International (VFF), Bombardier, Inc. Class B (BBD.B), Cronos Group (MJN) and Enbridge (ENB).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Computer Hardware
• Current Symbol: TSE:IMV
• CIK: N/A
• Web: www.imvaccine.com
• Phone: +1-902-4921819
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($6.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$37.99 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -508.58%
• Return on Assets: -61.78%

Debt

• Debt-to-Equity Ratio: 1,231.01
• Current Ratio: 2.93
• Quick Ratio: 2.32

Sales & Book Value

• Annual Sales: C$23 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 1.61
• Book Value: C($0.69) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,710,000
• Free Float: N/A
• Market Cap: C$13.12 million
• Optionable: Not Optionable
• Beta: 1.52